
|Videos|August 27, 2018
Dr. Sparano Discusses Unmet Needs in Metastatic Breast Cancer
Author(s)Joseph A. Sparano, MD
Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, Montefiore Medical Center, discusses unmet needs in metastatic breast cancer.
Advertisement
Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, Montefiore Medical Center, discusses unmet needs in metastatic breast cancer.
This remains an incurable disease, Sparano says, although there have been significant improvements in clinical outcomes over the last few years. For patients with estrogen receptor-positive, HER2-negative disease, the rise of CDK4/6 inhibitors has dramatically changed the management of that setting. These agents haven
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5



































